Second Sight

You might remember the Argus II implant from when it first gained market approval in the US back in 2013. The ambitious prosthesis is back, with researchers now looking to utilize the technology to treat patients with dry age-related macular degeneration (AMD).

The Argus II "bionic eye" has received U.S. market approval from the Food and Drug Administration (FDA).

Enrollment is complete for the Phase I trial of the electronic retinal implant known as The Argus II - a device which restores a basic level of sight using an external camera mounted in eyeglasses linked to a tiny array of 60 electrodes attached to the retina.

February 19, 2007 Patients who have gone blind are a step closer to perhaps one day regaining some of their sight with the news that the United States FDA ha